Novartis gains 8% in 6 months following FDA commissioner appointment
user-generated· price
Novartis gains 8% in 6 months following FDA commissioner appointment
Market overview
Novartis, with a robust pipeline and lower regulatory risk, will benefit from a stable FDA leadership team. Investors will rotate into Novartis as a defensive play during the transition period.
price prediction market
- Implied probability (Yes)
- 55%
Source: user-generated
More price markets
- Bitcoin price exceeds $150,000 by end of 2026 — 68% Yes
- Bitcoin price recovers to $50,000 by December 2026 — 62% Yes
- Bitcoin price exceeds $100,000 within 6 months of Clarity Act passage — 70% Yes
- Coinbase stock to rise 15% by June 2026 amid crypto regulation clarity — 72% Yes
- NY crypto tax revenue will exceed $200M in 2027 — 65% Yes
- Will stock drop >15% on next financing terms? — 45% Yes
- Will enGene raise additional equity financing before Q1 2027? — 80% Yes
- Trading volume on Kalshi’s crypto futures exceeds $500M in first month — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…